Exploiting the defensive sugars of HIV-1 for drug and vaccine design
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antige...
Principais autores: | Scanlan, C, Offer, J, Zitzmann, N, Dwek, R |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Nature Research
2007
|
Registros relacionados
-
Emerging principles for the therapeutic exploitation of glycosylation.
por: Dalziel, M, et al.
Publicado em: (2014) -
Sugar immunogens
por: Dwek, R, et al.
Publicado em: (2009) -
Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
por: Dunlop, D, et al.
Publicado em: (2008) -
Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
por: Dunlop, D, et al.
Publicado em: (2008) -
Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
por: Dunlop, D, et al.
Publicado em: (2009)